# The Voices of our Elders

> **NIH NIH S06** · WABANAKI HEALTH AND WELLNESS · 2024 · $542,576

## Abstract

RESEARCH PROJECT: ABSTRACT
The number of American Indians aged 65 and older will triple to 1,624,000 by 2050, while the number of those
aged 85 and older will increase 7-fold to 300,000. These demographic trends raise concerns about the population
prevalence of Alzheimer’s disease and related dementias (ADRD) and its prodrome, mild cognitive impairment,
and the need for health care for ADRD. American Indians also experience a disproportionate burden of ADRD
risk factors, such as hypertension and type 2 diabetes. Available data on cognitive impairment and ADRD among
American Indian elders remain limited. Furthermore, the few existing studies on dementia in American Indians
have been limited to the midwestern and western US. There exists a need for studies that can estimate, track,
prevent, and, eventually treat ADRD. We also need to weigh the economic costs of appropriate public health
interventions for American Indians in the eastern half of the US. Accordingly, we propose the first population-
based study designed to systematically characterize ADRD among American Indian communities in the eastern
US. This effort will be a partnership between Washington State University, the University of Miami, and Wabanaki
Public Health, a tribally founded and directed public health district serving all 4 federally recognized tribes in
Maine, collectively known as the Wabanaki tribes. Approximately 875 American Indians aged 55 and older reside
in the service delivery areas of the 4 tribes, yet nothing is known about their cognitive function or clinical
prevalence ADRD or multiple cognitive impairment. We will use tribal rolls to invite all American Indians aged 55
and older to participate in a population-based epidemiologic study (n = 650, assuming 75% participation
based on prior Wabanaki response rates) to assess cognitive function and ADRD risk factors, and to identify
people with probable cognitive impairment or ADRD. We will also conduct a case-control validation study with
a subset of participants (n = 260) to validate our cognitive screening results against the results of a clinical
diagnostic interview, the gold standard in ADRD. Finally, we will conduct a health economics analysis of current
and future costs associated with ADRD. Our Specific Aims are to: 1) Conduct an epidemiologic study of health
and lifestyle risk factors for ADRD and cognitive decline, and screen for prevalent ADRD and mild cognitive
impairment among Wabanaki tribal members aged 55 and older; 2) Conduct a case-control validation study
comparing screening results from Aim 1 to a clinical diagnostic interview; and 3) Use data from Aims 1 and 2 to
estimate current and future direct and indirect costs associated with ADRD and mild cognitive impairment
morbidity and treatment. Our study will contribute invaluable public health data for Wabanaki Public Health and
American Indians nationally, and contribute to the development of ADRD-related health interventions tailored to
the needs of ...

## Key facts

- **NIH application ID:** 10914150
- **Project number:** 5S06GM142115-04
- **Recipient organization:** WABANAKI HEALTH AND WELLNESS
- **Principal Investigator:** Patrik Lennart Johansson
- **Activity code:** S06 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $542,576
- **Award type:** 5
- **Project period:** 2021-09-16 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10914150

## Citation

> US National Institutes of Health, RePORTER application 10914150, The Voices of our Elders (5S06GM142115-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10914150. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
